» Articles » PMID: 31436258

Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation Via Regulating Cyclin E

Overview
Journal Med Sci Monit
Date 2019 Aug 23
PMID 31436258
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Cervical cancer is one of the most lethal gynecologic malignancies worldwide. The objective of this study was to assess the role of MNX1 in cervical cancer and its underlying mechanisms. MATERIAL AND METHODS The expression of motor neuron and pancreas homeobox 1 (MNX1) in immortal epithelial cervical cell line ECT, cervical cancer cell HeLa, and SiHa and cervical cancer, as well as in adjacent noncancer tissues, was detected and analyzed. CCK-8 and colony formation assays were performed to evaluate the effects of MNX1 overexpression on cervical cancer cell proliferation. Transwell assay was used to detect migration and invasion after MNX1 knockdown or overexpression. Real-time PCR and Western blotting were used to examine MNX1 and cell cycle regulator expression. RESULTS Data from our study indicated that MNX1 was upregulated both in cervical cancer cell lines and cervical cancer tissues. The high levels of MNX1 are related to advanced stages and lymph nodes metastasis. The overexpression of MNX1 promoted cervical cancer cells proliferation, migration, and invasion. Moreover, MNX1 upregulated 2 critical cell cycle regulators, CCNE1 and CCNE2. CONCLUSIONS These findings reveal MNX1 as a novel oncogene of cervical cancer and indicate MNX1 is a promising therapeutic and prognostic biomarker.

Citing Articles

Identification of Key Genes Correlated with Economic Trait Superiorities and Their SNP Screening Through Transcriptome Comparisons, WGCNA and Pearson Correlation Coefficient in the Sea Cucumber Apostichopus Japonicus.

Sun J, Wang H, Zhan Y, Zhao T, Li C, Cheng C Mar Biotechnol (NY). 2024; 27(1):12.

PMID: 39601948 DOI: 10.1007/s10126-024-10384-y.


The effect of LNCRNA SHANK3 on the malignant development of gastric cancer cells by regulating the miR-4530/MNX1.

Zhao L, Xiang Y, Wang J, Shen C, Liu H, Zong Q Transl Oncol. 2024; 46:102000.

PMID: 38852278 PMC: 11220521. DOI: 10.1016/j.tranon.2024.102000.


A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer.

Li J, Liu H, Zhang H, Li J, Liang Z J Cancer. 2023; 14(14):2739-2750.

PMID: 37779874 PMC: 10539396. DOI: 10.7150/jca.86718.


Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.

Rebbeck C, Xian J, Bornelov S, Geradts J, Hobeika A, Geiger H Nat Commun. 2022; 13(1):3399.

PMID: 35697697 PMC: 9192778. DOI: 10.1038/s41467-022-30573-4.


Functional New Transcription Factors (TFs) Associated with Cervical Cancer.

Jiang Y, Chen S J Healthc Eng. 2022; 2022:8381559.

PMID: 35126951 PMC: 8808228. DOI: 10.1155/2022/8381559.


References
1.
Tian T, Wang M, Zhu Y, Zhu W, Yang T, Li H . Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer. Mol Ther Nucleic Acids. 2018; 13:399-406. PMC: 6205149. DOI: 10.1016/j.omtn.2018.09.014. View

2.
Fu Y, Kohaar I, Moore L, Lenz P, Figueroa J, Tang W . The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res. 2014; 74(20):5808-18. PMC: 4203382. DOI: 10.1158/0008-5472.CAN-14-1531. View

3.
Neufing P, Kalionis B, Horsfall D, Ricciardelli C, Stahl J, Vivekanandan S . Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues. Anticancer Res. 2003; 23(2B):1479-88. View

4.
Belloni E, Martucciello G, Verderio D, Ponti E, Seri M, Jasonni V . Involvement of the HLXB9 homeobox gene in Currarino syndrome. Am J Hum Genet. 2000; 66(1):312-9. PMC: 1288336. DOI: 10.1086/302723. View

5.
Harrison K, Thaler J, Pfaff S, Gu H, Kehrl J . Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet. 1999; 23(1):71-5. DOI: 10.1038/12674. View